Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus rifampicin
- 31 October 1994
- journal article
- clinical trial
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 75 (5) , 341-347
- https://doi.org/10.1016/0962-8479(94)90079-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effectiveness of Rifampin, Rifabutin, and Rifapentine for Preventive Therapy of Tuberculosis in MiceAmerican Review of Respiratory Disease, 1993
- Rifabutin absorption in humans: Relative bioavailability and food effectClinical Pharmacology & Therapeutics, 1992
- Assessment of a Daily Combined Preparation of Isoniazid, Rifampin, and Pyrazinamide in a Controlled Trial of Three 6-Month Regimens for Smear-positive Pulmonary TuberculosisAmerican Review of Respiratory Disease, 1991
- Controlled Trial of 2, 4, and 6 Months of Pyrazinamide in 6-Month, Three-Times-Weekly Regimens for Smear-positive Pulmonary Tuberculosis, Including an Assessment of a Combined Preparation of Isoniazid, Rifampin, and Pyrazinamide: Results at 30 MonthsAmerican Review of Respiratory Disease, 1991
- Autoinduction of rifabutin metabolism in manXenobiotica, 1990
- Intraphagocytic penetration of antibioticsJournal of Antimicrobial Chemotherapy, 1988
- Rifabutine: Minimal Inhibitory and Bactericidal Concentrations forMycobacterium tuberculosisAmerican Review of Respiratory Disease, 1988
- Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjectsEuropean Journal of Clinical Pharmacology, 1988
- Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: Final reportTubercle, 1986